Following three weeks of trial, lawyers battling over the role Johnson’s Baby Powder may have played in a woman’s death from ovarian cancer spent four hours Thursday rehashing expert testimony and whether the company had any reason to think its talc-based product posed a health risk. 

“This is a big case with big issues that affect thousands of people, and about Johnson & Johnson protecting its corporate image,” said lead plaintiffs attorney R. Allen Smith, representing the granddaughter and estate of Diane Brower, who died in 2016. Brower purportedly used the powder on her vaginal area for more than 15 years before stopping around 1980.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]